Regeneron presents phase 3 data for cat and birch allergy antibody treatments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. AVGO
3. NVDA
4. ALNY
5. ATTO
6. BRVE
7. APO
8. OKE
9. SRE
10. CNS

Go back to Regeneron presents phase 3 data for cat and birch allergy antibody treatments
Regeneron (NASDAQ: REGN) Delayed: 794.19 --0 (-0%)
Previous Close $794.19    52 Week High $592.36 
Open $794.19    52 Week Low $325.35 
Day High $794.19    P/E 208.45 
Day Low $794.19    EPS $3.81 
Volume 15,764